Skip to main content
OpenTrials

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

NCT06619561

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Ronald Regan UCLA Medical Center Los Angeles, California, United States
  • University of California Irvine Health Orange, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

NCT06682169

Conditions
Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • The Southwest Hospital of AMU Chongqing, Chongqing Municipality, China
View all 41 locations
View Trial Details
Recruiting

IS-free Treg HaploHCT

NCT04678401

Conditions
Bone Marrow Diseases, Graft vs Host Disease, Hematologic Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

NCT05866302

Conditions
Chronic Lung Disease, Graft Versus Host Disease, Graft vs Host Disease, +2 more
Locations
  • Stanford Hospital Stanford, California, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Boston, Massachusetts, United States
  • The University of Michigan Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions